Personalized prediction for a 70 year old man who takes Magnesium Glycinate, Vitamin D3 (an AI-powered real world drug study)

Summary:

This is a personalized prediction of potential side effects and undetected conditions for up to one year, if you would have adverse effects. The study is created by eHealthMe based on data from the FDA.


On Jan, 21, 2026, 2,447,477 related reports were analyzed:

What are the drugs?

What are the conditions?

What are the symtoms?


Potential side effects:

Acute kidney failure
  • 12.35% for males aged 70 (±5) who have calcium deficiency
Chronic kidney disease
  • 16.05% for males aged 70 (±5) who have calcium deficiency
Conjunctivitis
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Death
  • 5.44% for males aged 70 (±5) who take magnesium glycinate
  • 5.44% for males aged 70 (±5) who take vitamin d3
Eye disorder
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Hyperparathyroidism secondary
  • 8.64% for males aged 70 (±5) who have calcium deficiency
Melanocytic naevus
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Nephrogenic anaemia
  • 7.41% for males aged 70 (±5) who have calcium deficiency
Oral mucosal exfoliation
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Oral pain
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Rashes
  • 7.41% for males aged 70 (±5) who have calcium deficiency
Scab
  • 6.17% for males aged 70 (±5) who have calcium deficiency

Potential co-existing conditions:

Anaemia
  • 14.81% for males aged 70 (±5) who have calcium deficiency
Anticoagulant therapy
  • 9.88% for males aged 70 (±5) who have calcium deficiency
Calcium deficiency
  • 100.0% for males aged 70 (±5) who have calcium deficiency
Cardiac disorder
  • 7.41% for males aged 70 (±5) who have calcium deficiency
Cardiac failure
  • 7.41% for males aged 70 (±5) who have calcium deficiency
Constipation
  • 13.58% for males aged 70 (±5) who have calcium deficiency
Diabetes
  • 16.05% for males aged 70 (±5) who have calcium deficiency
Diarrhea
  • 8.64% for males aged 70 (±5) who have calcium deficiency
Fluid retention
  • 9.88% for males aged 70 (±5) who have calcium deficiency
Gastroesophageal reflux disease
  • 27.16% for males aged 70 (±5) who have calcium deficiency
Heart attack
  • 6.17% for males aged 70 (±5) who have calcium deficiency
High blood cholesterol
  • 32.1% for males aged 70 (±5) who have calcium deficiency
High blood pressure
  • 44.44% for males aged 70 (±5) who have calcium deficiency
  • 5.76% for males aged 70 (±5) who take magnesium glycinate
  • 5.76% for males aged 70 (±5) who take vitamin d3
Hyperkalemia
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Hyperuricaemia
  • 8.64% for males aged 70 (±5) who have calcium deficiency
Hypothyroidism
  • 8.64% for males aged 70 (±5) who have calcium deficiency
Hypovitaminosis
  • 9.88% for males aged 70 (±5) who have calcium deficiency
Infection
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Inflammation
  • 7.41% for males aged 70 (±5) who have calcium deficiency
Multiple myeloma
  • 13.58% for males aged 70 (±5) who have calcium deficiency
  • 5.51% for males aged 70 (±5) who take magnesium glycinate
  • 5.51% for males aged 70 (±5) who take vitamin d3
Nasopharyngitis
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Nausea
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Neuralgia
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Osteoporosis
  • 9.88% for males aged 70 (±5) who have calcium deficiency
Pain
  • 29.63% for males aged 70 (±5) who have calcium deficiency
Prostate cancer
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Rheumatoid arthritis
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Rickets
  • 24.69% for males aged 70 (±5) who have calcium deficiency
Type 2 diabetes
  • 6.17% for males aged 70 (±5) who have calcium deficiency
Vitamin supplementation
  • 6.17% for males aged 70 (±5) who have calcium deficiency

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

How the study uses the data?

The study is based on gender, age, active ingredients of any drugs used, and more. Other drugs that have the same active ingredients (e.g. generic drugs) are considered.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: